Back
For best output, select "Paper Size" as "A4" and "Margin" as "0" or "None".
To save or print to PDF, please select Print Destination > Save as PDF, enable Background Graphics under "More Settings", then click "Save".
During the congress, E-Posters will be accessible to all participants on the congress website 24/7, as well as in the E-poster stations in the congress center.
Preparing your E-Poster
Please review the E-Poster format requirements carefully when preparing your E-Poster. Should your E-Poster not meet the mentioned requirements, it may not be displayed as described above.
E-Poster Submission Deadline
Please prepare and upload your E-Poster no later than March 14, 2026 11.59PM CET. After this date, you will no longer be able to prepare and upload your E-poster and it will not be displayed and accessible on the congress website.
Please follow the instructions below to input your abstract title.
Abstract titles should be brief and reflect the content of the abstract.
Cerebrovascular disease remains one of the leading causes of morbidity and mortality in End-stage renal disease patients undergoing hemodialysis. Hemodialysis patients often present with multiple comorbidities including hypertension, diabetes, coronary/peripheral artery disease, malignancy, atrial fibrillation, dyslipidemia, bleeding dyscrasias, and even a history of COVID-19 infection – each of which is independently associated with an elevated risk of cerebrovascular event. Understanding the magnitude of this problem and the underlying mechanisms is crucial for developing targeted preventive strategies and improving patient outcomes.
This is a retrospective, analytical, cross-sectional chart review study aimed at determining the prevalence and outcomes of patients on maintenance hemodialysis who succumb to cerebrovascular diseases. The chart review is utilized to gather the necessary data.
More than half of the patients had ischemic stroke (60.78%) compared with those with hemorrhagic stroke (39.22%). Most affected were older patients in the 61-80 age group with only 1.96% under 40 years old. Thirty-three percent (33.33%) of these patients expired after acute cerebrovascular events and hemorrhagic stroke was associated with a markedly higher mortality rate (55.00% vs. 19.35%, p = 0.005), while ischemic stroke patients were more likely to be discharged improved (77.42% vs. 35.00%).
End-stage renal disease patients undergoing hemodialysis are at significantly higher risk of cerebrovascular events compared to the general population. Ischemic stroke is more common compared to hemorrhagic stroke, with the latter requiring longer hospital stay and portends a poorer prognosis. Preventive measures such as control of comorbidities are essential in reducing the incidence of cerebrovascular events and improving overall outcomes in hemodialysis patients.
